Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers.

S Oswald, A Nassif, C Modess, M Keiser, A Ulrich, D Runge, U Hanke, D Lütjohann, A Engel, W Weitschies, W Siegmund

Department of Clinical Pharmacology, University of Greifswald, Greifswald, Germany. stefan.oswald@uni-greifswald.de

Clinical pharmacology and therapeutics 2011 Apr

filter terms:

Immunosuppressive therapy is frequently associated with hypercholesterolemia, calling for lipid-lowering treatment without adverse drug interactions. One option is treatment with the cholesterol absorption inhibitor ezetimibe. We have shown in vitro that ezetimibe and tacrolimus may interact in competition for intestinal UGT1A1 and ABCB1 at concentrations reached in gut lumen after oral administration. However, this clinical study in healthy volunteers showed that the expected pharmacokinetic interaction between ezetimibe and tacrolimus is not of clinical relevance.

Citation

S Oswald, A Nassif, C Modess, M Keiser, A Ulrich, D Runge, U Hanke, D Lütjohann, A Engel, W Weitschies, W Siegmund. Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clinical pharmacology and therapeutics. 2011 Apr;89(4):524-8